Leptin's mitogenic effect in human liver cancer cells requires induction of both methionine adenosyltransferase 2A and 2β

Hepatology

Volumn 47, Issue 2, 2008, Pages 521-531

  Ramani, Komal ^a   Yang, Heping ^a   Xia, Meng ^a   Ara, Ainhoa Iglesias ^a   Mato, José M ^b   Lu, Shelly C ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DERIVATIVE; LEPTIN; METHIONINE ADENOSYLTRANSFERASE; METHIONINE ADENOSYLTRANSFERASE 2A; METHIONINE ADENOSYLTRANSFERASE 2BETA; METHYLTHIOADENOSINE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; S ADENOSYLMETHIONINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CATALYST; CELL GROWTH; CELL STRAIN HEPG2; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME ACTIVITY; ENZYME INDUCTION; FIBROGENESIS; GENE; GENE EXPRESSION REGULATION; GENE INDUCTION; HUMAN; HUMAN CELL; LIVER CANCER; LIVER CELL; LIVER FIBROSIS; MALE; MAT1A GENE; MAT2A GENE; MAT2BETA GENE; MITOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

ANIMALS; CELL LINE, TUMOR; ENZYME INDUCTION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HEPATOCYTES; HUMANS; LEPTIN; LIVER NEOPLASMS; MALE; METHIONINE ADENOSYLTRANSFERASE; MICE; MICE, INBRED C57BL; RNA; RNA, NEOPLASM;

EID: 39549114272     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.22064     Document Type: Article

References (34)

1. Ikejima K, Honda H, Yoshikawa M, Hirose M, Kitamura T, Takei Y, et al. Leptin augments inflammatory and profibrogenic responses in the murine liver induced by hepatotoxic chemicals. HEPATOLOGY 2001;34:288-297.
2. Saglam K, Aydur E, Yilmaz M, Göktas S. Leptin influences cellular differentiation and progression in prostate cancer. J Urol 2003;169:1308-1311.
3. Sharma D, Saxena NK, Vertino PM, Anania FA. Leptin promotes the proliferative response and invasiveness in human endometrial cancer cells by activating multiple signal transduction pathways. Endocr Relat Cancer 2006;13:629-640.
4. Saxena NK, Titus MA, Ding X, Floyd J, Srinivasan S, Sitaram SV, et al. Leptin as a novel profibrogenic cytokine in hepatic stellate cells: mitogenesis and inhibition of apoptosis mediated by exttacellular regulated kinase (Erk) and Akt phosphorylation. FASEB J 2004;18:1612-1614.
5. Henriksen JH, Holst JJ, Møller S, Brinch K, Bendtsen F. Increased circulating leptin in alcoholic cirrhosis: relation to release and disposal. HEPATOLOGY 2003;29:1818-1824.
6. Comlekci A, Akpinar H, Yesil S, Okan I, Ellidokuz E, Okan A, et al. Serum leptin levels in patients with liver cirrhosis and chronic viral hepatitis. Scand J Gastroenterol 2003;7:779-786.
7. Saxena NK, Ikeda K, Rockey DC, Friedman SL, Anania FA. Leptin in hepatic fibrosis: evidence for increased collagen production in stellate cells and lean littermates of ob/ob mice. HEPATOLOGY 2002;35:762-771.
8. Kitade M, Yoshiji H, Kojima H, Ikenaka Y, Noguchi R, Kaji K, et al. Leptin-mediated neovascularization is a prerequisite for progression of non-alcoholic steatohepatitis in rats. HEPATOLOGY 2006;44:983-991.
9. Saxena NK, Sharma D, Ding X, Lin S, Marra F, Merlin D, et al. Concomitant activation of the JAK/STAT, PI3K/AKT, and ERK signaling is involved in leptin-mediated promotion of invasion and migration of hepatocellular carcinoma cells. Cancer Res 2007;67:2497-2507.
10. Mato JM, Corrales FJ, Lu SC, Avila MA. S-adenosylmethionine: a control switch that regulates liver function. FASEB J 2002;16:15-26.
11. Clarke SG. Inhibition of mammalian protein methyltransferases by 5′-methylthioadenosine (MTA): a mechanism of action of dietary SAMe? Enzymes 2006;24:467-493.
12. Kotb M, Mudd SH, Mato JM, Geller AM, Kredich NM, Chou JY, et al. Consensus nomenclature for the mammalian methionine adenosyltransferase genes and gene products. Trends Genet 1997;13:51-62.
13. Halim AB, LeGros L, Geller AM, Kotb M. Expression and functional interaction of the catalytic and regulatory subunits of human methionine adenosyltransferase in mammalian cells. J Biol Chem 1999;274:29720-29725.
14. Gil B, Casado M, Pajares MA, Boscá L, Mato JM, Martín-Sanz P, et al. Differential expression pattern of SAM synthetase isoenzymes during rat liver development. HEPATOLOGY 1996;24:876-881.
15. Horikawa S, Tsukada K. Molecular cloning and developmental expression of a human kidney S-adenosylmethionine synthetase. FEBS Lett 1992;312:37-41.
16. Yang HP, Sadda MR, Li M, Zeng Y, Chen LX, Bae WJ, et al. S-Adenosylmethionine and its metabolite induce apoptosis in HepG2 cells: role of protein phosphatase 1 and Bcl-xS. HEPATOLOGY 2004;40:221-231.
17. Huang ZZ, Mao Z, Cai J, Lu SC. Changes in methionine adenosyltransferase during liver regeneration in the rat. Am J Physiol 1998;275:G14-G21.
18. Cai J, Mao Z, Hwang JJ, Lu SC. Differential expression of methionine adenosyltransferase genes influences the rate of growth of human hepatocellular carcinoma cells. Cancer Res 1998;58:1444-1450.
19. Pañeda C, Gorospe I, Herrera B, Nakamura T, Fabregat I, Varela-Nieto I. Liver cell proliferation requires methionine adenosyltransferase 2A mRNA upregulation. HEPATOLOGY 2002;35:1381-1391.
20. Martínez-Chantar ML, García-Trevijano ER, Latasa MU, Martín-Duce A, Fortes P, Caballería J, et al. Methionine adenosyltransferase II β subunit gene expression provides a proliferative advantage in human hepatoma. Gastroenterology 2003;124:940-948.
21. Yang HP, Magilnick N, Noureddin M, Mato JM, Lu SC. Effect of hepatocyte growth factor on methionine adenosyltransferase genes and growth is cell density-dependent in HepG2 cells. J. Cell Physiol 2007;210:766-773.
22. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002;3:34.1-34.11.
23. Giulietti A, Overbergh L, Valckx D, Decallonne B, Bouillon R, Mathieu C. An overview of real-time quantitative PCR: applications to quantify cytokine gene expression. Methods 2001;25:386-401.
24. Yang HP, Sadda MR, Yu V, Zeng Y, Lee TD, Ou XP, et al. Induction of human methionine adenosyltransferase 2A expression by tumor necrosis factor alpha: role of NF-κB and AP-1. J Biol Chem 2003;278:50887-50896.
25. Yang HP, Huang ZZ, Zeng ZH, Chen CJ, Selby RR, Lu SC. Role of promoter methylation in increased methionine adenosyltransferase 2A expression in human liver cancer. Am J Physiol 2001;280:G184-G190.
26. Farrar C, Clarke S. Altered levels of S-adenosylmethionine and S-adenosylhomocysteine in the brains of L-isoaspartyl (D-aspartyl) O-methyltransferase-deficient mice. J Biol Chem 2002;277:27856-27863.
27. Hoda MR, Keely SJ, Bertelsen LS, Junger WG, Dharmasena D, Barrett KE. Leptin acts as a mitogenic factor for colonic cancer cells. Br J Surg 2007;94:346-354.
28. Hoggard N, Hunter L, Duncan JS, Williams LM, Trayhurn P, Mercer, JG. Leptin and leptin receptor mRNA and protein expression in the murine fetus and placenta. Proc Natl Acad Sci U S A 1997;94:11073-11078.
29. Briscoe CP, Hanif S, Arch JRS, Tadayyon M. Leptin receptor long-form signaling in a human liver cell line. Cytokine 2001;14:225-229.
30. Marino M, Acconcia F, Trentalance A. Biphasic estradiol-induced AKT phosphorylation is modulated by PTEN via MAP kinase in HepG2 cells. Mol Biol Cell 2003;14:2583-2591.
31. Wennstrom S, Downward J. Role of phosphoinositide 3-kinase in activation of ras and mitogen-activated protein kinase by epidermal growth factor. Mol Cell Biol 1999;19:4279-4288.
32. Martínez-Chantar ML, Vázquez-Chantada M, Garnacho M, Latasa MU, Varela-Rey M, Dotor J, et al. S-adenosylmethionine regulates cytoplasmic HuR via AMP-activated kinase. Gastroenterology 2006;131:223-232.
33. Garcia-Trevijano ER, Martínez-Chantar ML, Latasa MU, Mato JM, Avila MA. NO sensitizes rat hepatocytes to hepatocyte growth factor-induced proliferation through the modulation of S-adenosylmethionine levels. Gastroenterology 2002;122:1355-1363.
34. Corrales F, Giménez A, Alvarez L, Caballería J, Pajares MA, Andreu H, et al. S-adenosylmethionine treatment prevents carbon tetrachloride-induced S-adenosylmethionine synthetase inactivation and attenuates liver injury. HEPATOLOGY 1992;16:1022-1027.